Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100050865Phase 4Recruiting
Phase 4, open-label trial of tripterygium wilfordii polyglycosides, adalimumab and methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine. Primary endpoints: Low disease activity rate and Clinical remission rate. Started Jun 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100050865.